Suppr超能文献

UNC13A 影响意大利肌萎缩侧索硬化症患者的生存:一项基于人群的研究。

UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study.

机构信息

ALS Center, Department of Neuroscience, University of Torino, and Azienda Ospedale Università San Giovanni Battista, Torino, Italy.

出版信息

Neurobiol Aging. 2013 Jan;34(1):357.e1-5. doi: 10.1016/j.neurobiolaging.2012.07.016. Epub 2012 Aug 22.

Abstract

The common variant rs12608932, located within an intron of UNC13A gene on chromosome 19p13.3, has been suggested to influence susceptibility to amyotrophic lateral sclerosis (ALS), as well as survival, in patients of north European descent. To examine this possibility further, we evaluated the association of rs12608932 with susceptibility and survival in a population-based cohort of 500 Italian ALS patients and 1457 Italian control samples. Although rs12608932 was not associated with ALS susceptibility in our series (p = 0.124), it was significantly associated with survival under the recessive model (median survival for AA/AC genotypes = 3.5 years [interquartile range, 2.2-6.4]; CC = 2.5 years [interquartile range, 1.6-4.2]; p = 0.017). Furthermore, rs12608932 genotype remained an independent prognostic factor in Cox multivariable analysis adjusting for other factors known to influence survival (p = 0.023). Overall, minor allele carrier status of rs12608932 was strongly associated with an approximate 1-year reduction of survival in ALS patients, making it a significant determinant of phenotype variation. The identification of UNC13A as a modifier of prognosis among sporadic ALS patients potentially provides a new therapeutic target aimed at slowing disease progression.

摘要

位于 19p13.3 染色体 UNC13A 基因内含子中的常见变体 rs12608932 被认为会影响北欧裔 ALS 患者的易感性和生存。为了进一步研究这种可能性,我们评估了 rs12608932 与 500 名意大利 ALS 患者和 1457 名意大利对照样本的基于人群的队列中易感性和生存的相关性。尽管 rs12608932 在我们的研究中与 ALS 易感性无关(p = 0.124),但它在隐性模型下与生存显著相关(AA/AC 基因型的中位生存时间为 3.5 年[四分位间距,2.2-6.4];CC 为 2.5 年[四分位间距,1.6-4.2];p = 0.017)。此外,在调整其他已知影响生存的因素后,rs12608932 基因型在 Cox 多变量分析中仍然是一个独立的预后因素(p = 0.023)。总的来说,rs12608932 的次要等位基因携带者状态与 ALS 患者的生存时间大约减少 1 年密切相关,使其成为表型变异的重要决定因素。UNC13A 作为散发性 ALS 患者预后的修饰因子的鉴定,可能为减缓疾病进展提供了一个新的治疗靶点。

相似文献

3
UNC13A is a modifier of survival in amyotrophic lateral sclerosis.UNC13A 是肌萎缩侧索硬化症生存的修饰因子。
Neurobiol Aging. 2012 Mar;33(3):630.e3-8. doi: 10.1016/j.neurobiolaging.2011.10.029. Epub 2011 Nov 25.

引用本文的文献

5
Role of the UNC13 family in human diseases: A literature review.UNC13家族在人类疾病中的作用:文献综述。
AIMS Neurosci. 2023 Dec 6;10(4):388-400. doi: 10.3934/Neuroscience.2023029. eCollection 2023.
8
The era of cryptic exons: implications for ALS-FTD.隐匿外显子的时代:对 ALS-FTD 的影响。
Mol Neurodegener. 2023 Mar 15;18(1):16. doi: 10.1186/s13024-023-00608-5.
10
in amyotrophic lateral sclerosis: from genetic association to therapeutic target.在肌萎缩侧索硬化症中:从遗传关联到治疗靶点。
J Neurol Neurosurg Psychiatry. 2023 Aug;94(8):649-656. doi: 10.1136/jnnp-2022-330504. Epub 2023 Feb 3.

本文引用的文献

3
C9ORF72 hexanucleotide repeat expansions in the Italian sporadic ALS population.意大利散发性 ALS 人群中的 C9ORF72 六核苷酸重复扩展。
Neurobiol Aging. 2012 Aug;33(8):1848.e15-20. doi: 10.1016/j.neurobiolaging.2012.02.011. Epub 2012 Mar 13.
6
UNC13A is a modifier of survival in amyotrophic lateral sclerosis.UNC13A 是肌萎缩侧索硬化症生存的修饰因子。
Neurobiol Aging. 2012 Mar;33(3):630.e3-8. doi: 10.1016/j.neurobiolaging.2011.10.029. Epub 2011 Nov 25.
7
Munc13-1 is required for presynaptic long-term potentiation.Munc13-1 对于突触前长时程增强是必需的。
J Neurosci. 2011 Aug 17;31(33):12053-7. doi: 10.1523/JNEUROSCI.2276-11.2011.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验